BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Aequim Alternative Investments LP's Holding History (CIK: 0001728201)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 7,500,000 Value ($000) $5,976 Avg Close — Range —
Q1 2024
Shares 15,000,000 Value ($000) $12,290 Avg Close — Range —
Q4 2023
Shares 15,000,000 Value ($000) $12,779 Avg Close — Range —
Q3 2023
Shares 20,000,000 Value ($000) $15,000 Avg Close — Range —
Q2 2023
Shares 30,000,000 Value ($000) $18,566 Avg Close — Range —
Q1 2023
Shares 31,000,000 Value ($000) $20,068 Avg Close — Range —
Q4 2022
Shares 31,000,000 Value ($000) $11,838 Avg Close — Range —
Q3 2022
Shares 31,000,000 Value ($000) $13,755 Avg Close — Range —
Q2 2022
Shares 31,000,000 Value ($000) $13,135 Avg Close — Range —
Q1 2022
Shares 35,000,000 Value ($000) $16,380 Avg Close — Range —